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Background: Despite performing surgical treatment, chronic rhinosinusitis 
coexisting with polyposis has recurrent episodes. Considering the strong 
association between nasal polyposis and asthma, the role of Vitamin D 
deficiency has been demonstrated in most of the asthma attacks. 
 
Aim: To investigate the serum level of 25-hydroxy vitamin D in chronic rhino 
sinusitis among the patients with and without nasal polyposis. 
 
Methods: A retrospective review from 36 cases was conducted. Patients were 
selected from a computerized rhinoplasty database of operative cases. The 
database was used to extract a subset population that had received the dome cut 
procedure and had follow-up data for 6 months or more after surgery. Patient 
satisfaction, physician evaluation, physical examination, blinded comparison of 
preoperative and postoperative photographs, and revision surgery necessitation 
were also analyzed in this review of results and complications. 
 
Results: We found severe vitamin D deficiency in 47.4% of the polyposis 
patients, while this rate decreased to 13.3% in the control group (p=0.004). 
Based on the age group classification, there was no statistically significant 
difference in terms of the vitamin D deficiency between the polyposis patients 
and control group (p=0.66). 
 
Conclusion: Vitamin D deficiency can be associated with the prevalence of 
nasal polyposis in the patients affected by chronic rhinosinusitis. Further studies 
can prove the essential role of vitamin D in pathogenesis of nasal polyposis. 
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There is no distinct etiology for nasal polyposis. 
Although the medical and surgical treatment 
methods are available, the frequent recurrence 
is a common event. Reported relapse 
prevalence rate in nasal polyposis is around 
60%, which needs the revision surgery in 47% 
of the cases (1).The coexistence of asthma and 
aspirin intolerance in nasal polyposis (samter 
triad) increased the recurrence rate up to 36% to 
96% (2, 3). 
In addition to the essential role of vitamin D in 
calcium hemostasis and deposition of calcium 
in bones, it is considered as an important factor 
for balancing the immune system. 
Immune cells, lymphocytes, antigen-presenting 
cells, intestinal epithelial cell, and renal cells 
contain vitamin D receptor. Beside the 
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paracrine role in innate and acquired immunity, 
these cells are able to synthesis the active form 
of vitamin D (4).  
According to Laksi research, the level of 
vitamin D changes during the year and the 
lowest concentration is represented in winter, 
which is associated with the increased 
respiratory infection (5). Several studies have 
indicated the link between decreasing level of 
vitamin D and the rising rate of asthma attack 
(6, 7). 
Considering the 29% prevalence rate of asthma 
in the polyposis patients (3); we analyzed the 
level of vitamin D in the nasal polyposis cases. 
 
Methods 
In this cross-sectional study, 38 patients with 
nasal polyposis and 38 rhinoplasty patients 
without polyposis who were referred to 
otorhinolaryngology department of Loghman 
Hakim hospital, Shahid Beheshti University of 
Medical Sciences, during 2015-2016 were 
enrolled. Also, they had no systemic disease. 
The patients with any mass or antrochoanal 
polyp were excluded from the study. The serum 
level of vitamin D in all cases was detected 
using immunoassay examination. The basic 
information including demographics, the 
history of asthma, and aspirin intolerance were 
gathered in questionnaires.  
In order to determine the severity of vitamin D 
deficiency, vitamin D levels were classified 
into three categories as follows: vitamin D 
deficiency, vitamin D insufficiency, and 
sufficient vitamin D that were represented as 
serum vitamin D level of less than 10 
nanograms per deciliter (ng/dL), 11-30 ng/dL, 
and higher than 30 ng/dL, respectively (8). The 
medical ethics committee of Shahid Beheshti 
University of Medical Sciences approved this 
study. We obtained written informed consent 
from the eligible patients. 
Quantitative variables were presented with 
mean ± standard deviation, and then analyzed 
using independent t test and Mann – Whitney U 
test (the normality of data was not met). The 
chi-square test was applied for qualitative 
variables. Also, statistical analysis was 
performed using spss 18.0 (spss Inc., Chicago, 




In this study, a total of 76 patients including 32 
male and 44 female, were enrolled. The patients 
were classified into two groups as those with 
and without nasal polyposis. There was no 
significant statistically difference between both 
genders (p=0.49). The mean age of the 
polyposis patients was 43.47 ± 12.24 years old 
and in patients without polyposis was 
32.18 ± 9.87 years old, which represented a 
significant statistically difference (p˂0.001).  
The majority of the participants' ages were 
ranged from 31 to 50 years old (n=31, 40.8%). 
The average level of vitamin D was compared 
between two groups, which was not 
significantly different (polyposis group: 
24.47 ± 15.51 ng/dL vs non polyposis group: 
30.03 ± 16.4 ng/dL, p=0.13). Considering the 
classification of vitamin D levels; sever vitamin 
D deficiency (≤10 ng/dL) was diagnosed in 18 
polyposis patients (47.4%), and 5 cases (13.2%) 
from the other group, who were without 
polyposis. This difference was statistically 
significant (p=0.004) (Figure.1). 
The patients were categorized into three groups 
as follows: less than 30 years old (n=28, 
36.8%), 30-50 years old (n=31, 40.8%), and 
more than 50 years old (n=17, 22.4%). 
Frequency percentages of vitamin D deficiency 
were 28.8%, 32.3%, and 29.4%, respectively, 
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Figure 1: Comparison of vitamin D deficiency 
frequency between polyposis patients and control 
group. 
 
The association between gender and frequency 
percentage of vitamin D deficiency was not 
indicated (p=0.81, 59.4% male vs 63.6% 
female). The nasal polyposis concomitant with 
asthma (n=10, 26.3%) was detected in 5 
patients (50%) with vitamin D deficiency, 3 
patients (30%) with vitamin D insufficiency, 
and 2 cases (20%) with sufficient vitamin D, 
and in comparison with the nasal polyposis 
patients who were without asthma, there was no 
significant difference (p=0.95). 
Also, 7 cases (18.4%) of polyposis patients 
were affected by aspirin intolerance. There was 
no significant statistically difference in 
vitamin D deficiency diagnosis between the 
patients with and without aspirin intolerance 
(85.7% vs 62.3%, p=0.41). We found 13.1% 
patients with samter’s triad affected by vitamin 




The association between vitamin D deficiency 
and the severity of asthma has been proved in 
different studies (6, 7). Considering the 
association between asthma and polyposis (3); 
we analyzed the relationship between vitamin 
D level and polyposis. 
Accordingly, we found a significant difference 
in vitamin D deficiency between polyposis the 
patients and control group participants (47.4% 
vs 13.2%, p=0.004), while the mean level of 
vitamin D was not significantly different 
between the two groups. 
Wang's study showed that, there was a 
significant difference between the level of 
vitamin D in the polyposis patients and sinusitis 
cases without polyposis (21.4 ± 5.7 vs 
28.6 ± 6.2) (9), which confirmed the results of 
our work showing that the incidence of sever 
vitamin D deficiency is higher in the polyposis 
cases compared to the patients without 
polyposis (45.5% vs 6.3%). 
According to Dr. Heshmat's study, similar to 
our study, there was no significant difference in 
vitamin D level among various age groups. 
(10). In Heshmat's study, 47.2% was accounted 
for vitamin D deficiency in less than 50 years 
old patients, 45.7% for 50-60 years old, and 
44.2% for the patients who were older than 60 
years old. Moreover, no significant difference 
in vitamin D deficiency was illustrated in both 
genders. According to Muligan's study, in 
comparison with control group or CRSsNP 
cases, the patients who are affected by 
CRSwNP or AFRS represent the increased 
number of dandritic cells and declined level of 
25 hydroxy vitamin D. As a result of the 
essential role of DCs in regulating Th1/Th2 
skewing, they can be introduced as 
the mediators of the Th2 skewing, observed in 
CRSwith polyposis (11).Vitamin D facilitates 
the induction of T regulatory (12), extracellular 
matrix edema, and tissue remodeling, and its 
deficiency lead to down regulation of T 
regulatory and TGF-B in the polyposis patients. 
There was no statistically significant 
association between vitamin D deficiency in 
the patients affected by asthma or samter’s 
triad; however, as a result of inadequate 




In conclusion, vitamin D deficiency can affect 
the immune response to antigens. Therefore, 
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additional studies are needed to evaluate the 
effects of corrected vitamin D deficiency on the 
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